Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission, we hope you enjoy your experience

FRBRX Franklin Biotechnology Discovery R6

  • Fund
  • FRBRX
  • Price as of: Apr 23, 2019
  • $144.81 + $3.51 + 2.48%
  • Category
  • Health & Biotech Equities

FRBRX - Profile

Vitals

  • YTD Return 14.4%
  • 3 Yr Annualized Return 1.0%
  • 5 Yr Annualized Return 1.9%
  • Net Assets $1.2 B
  • Holdings in Top 10 48.3%

52 WEEK LOW AND HIGH

$144.81
$116.79
$171.11

Expenses

OPERATING RELATED FEES

  • Expense Ratio 0.63%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 26.95%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

STANDARD (TAXABLE)

$1,000,000

IRA

N/A

Investment Themes

CATEGORY

Health & Biotech Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return 14.4%
  • 3 Yr Annualized Total Return 3.4%
  • 5 Yr Annualized Total Return 5.9%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -0.17%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name Franklin Biotechnology Discovery Fund
  • Fund Family Name Franklin Templeton Investments
  • Inception Date May 01, 2013
  • Shares Outstanding 44027
  • Share Class Retirement
  • Currency USD
  • Domiciled Country United States

FRBRX - Performance

Return Ranking - Trailing

Period FRBRX Return Category Return Low Category Return High Rank in Category (%)
YTD 14.4% -6.1% 30.2% 11.76%
1 Yr -3.2% -23.3% 13.5% 67.65%
3 Yr 1.0%* -17.5% 19.9% 51.96%
5 Yr 1.9%* -11.2% 16.9% 48.98%
10 Yr N/A* -1.4% 16.7% N/A

* Annualized


Return Ranking - Calendar

Period FRBRX Return Category Return Low Category Return High Rank in Category (%)
2018 -18.2% -25.3% 7.7% 86.27%
2017 16.6% -10.8% 43.9% 51.96%
2016 -20.6% -29.8% 2.6% 79.41%
2015 -2.4% -20.4% 13.8% 53.92%
2014 29.3% -5.8% 31.5% 6.12%

Total Return Ranking - Trailing

Period FRBRX Return Category Return Low Category Return High Rank in Category (%)
YTD 14.4% -6.1% 30.2% 11.76%
1 Yr -3.2% -23.3% 22.0% 72.55%
3 Yr 3.4%* -17.5% 23.0% 59.80%
5 Yr 5.9%* -11.2% 18.9% 50.00%
10 Yr N/A* -1.4% 19.8% N/A

* Annualized


Total Return Ranking - Calendar

Period FRBRX Return Category Return Low Category Return High Rank in Category (%)
2018 -18.2% -25.3% 12.3% 87.25%
2017 19.3% -10.8% 45.8% 58.82%
2016 -16.8% -24.2% 8.7% 73.53%
2015 6.1% -16.6% 15.2% 47.06%
2014 34.3% -5.8% 36.7% 10.20%

NAV & Total Return History

FRBRX - Holdings

Concentration Analysis

FRBRX Category Low Category High FRBRX % Rank
Net Assets 1.2 B 14.9 M 46.5 B 56.86%
Number of Holdings 88 27 362 55.88%
Net Assets in Top 10 593 M 8.75 M 18.5 B 46.08%
Weighting of Top 10 48.27% 23.6% 77.8% 34.31%

Top 10 Holdings

  1. Alexion Pharmaceuticals Inc 8.19%

  2. Biogen Inc 6.69%

  3. Vertex Pharmaceuticals Inc 6.08%

  4. Array BioPharma Inc 5.26%

  5. Illumina Inc 4.69%

  6. Regeneron Pharmaceuticals Inc 4.39%

  7. Biomarin Pharmaceutical Inc 3.36%

  8. Gilead Sciences Inc 3.31%

  9. Amgen Inc 3.22%

  10. Heron Therapeutics Inc 3.10%


Asset Allocation

Weighting Return Low Return High FRBRX % Rank
Stocks
95.29% 77.38% 99.87% 77.45%
Cash
4.55% 0.00% 22.49% 22.55%
Other
0.15% -4.06% 2.34% 35.29%
Preferred Stocks
0.00% 0.00% 2.10% 91.18%
Convertible Bonds
0.00% 0.00% 0.28% 88.24%
Bonds
0.00% 0.00% 0.08% 88.24%

Stock Sector Breakdown

Weighting Return Low Return High FRBRX % Rank
Healthcare
94.91% 13.80% 99.84% 44.12%
Energy
0.08% 0.00% 0.08% 1.96%
Utilities
0.00% 0.00% 0.00% 88.24%
Technology
0.00% 0.00% 61.10% 93.14%
Real Estate
0.00% 0.00% 2.55% 88.24%
Industrials
0.00% 0.00% 10.61% 93.14%
Financial Services
0.00% 0.00% 9.31% 88.24%
Communication Services
0.00% 0.00% 0.00% 88.24%
Consumer Defense
0.00% 0.00% 0.88% 88.24%
Consumer Cyclical
0.00% 0.00% 7.87% 88.24%
Basic Materials
0.00% 0.00% 0.47% 88.24%

Stock Geographic Breakdown

Weighting Return Low Return High FRBRX % Rank
US
89.70% 61.73% 99.20% 23.53%
Non US
5.59% 0.00% 38.04% 79.41%

FRBRX - Expenses

Operational Fees

FRBRX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.63% 0.10% 2.98% 97.06%
Management Fee 0.58% 0.09% 1.25% 18.63%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee 0.15% 0.01% 0.40% 74.58%

Sales Fees

FRBRX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 2.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

FRBRX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 0.75% 2.00% N/A

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

FRBRX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 26.95% 0.00% 699.00% 19.61%

FRBRX - Distributions

Dividend Yield Analysis

FRBRX Category Low Category High FRBRX % Rank
Dividend Yield 0.00% 0.00% 0.01% 88.24%

Dividend Distribution Analysis

FRBRX Category Low Category High Category Mode
Dividend Distribution Frequency Annually Annually Annually Annually

Dividend Payout History


Net Income Ratio Analysis

FRBRX Category Low Category High FRBRX % Rank
Net Income Ratio -0.17% -2.15% 1.44% 46.08%

Capital Gain Distribution Analysis

FRBRX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually Annually

FRBRX - Managers

Tenure Analysis

Category Low

0.01

Category High

21.55

Category Average

10.01

Category Mode

18.93

Ad unit name:
mitre_webpage
Targets:
uri: '/frbrx-franklin-biotechnology-discovery-r6'
slot_name: 'A3-2'
Creative sizes: